Nevertheless, we also observed that, in addition to the lack of immune cell infiltration, tumor cells treated with CRC‐NeoVAS alone exhibited a high level of PD‐L1 and a low level of MHC, which was prone to T cell exhaustion and deficiency of tumor antigen presentation function. The gene discussed is CD274; the disease is colorectal carcinoma.